CURRENT ISSUE Current Issue Cover
VOL 9 • NO 7 NOV/DEC 2018
IN THIS ISSUE

Human Papillomavirus and Cancer

Pamela Hallquist Viale, RN, MS, CNS, ANP

Potential of Biosimilars to Increase Access to Biologics: Considerations for Advanced Practice Providers in Oncology

Sara M. Tinsley,(1) PhD, ARNP, AOCN®, Carolyn Grande,(2) CRNP, AOCNP®, Karin Olson,(3) PhD, PA-C, Leah Plato,(4) PA-C, MPH, CCRP, and Ira Jacobs,(5) MD, JD, MBA, FACS

The Stepped-Wedge Trial Design: Paving the Way for Cancer Care Delivery Research

Ya-Huei Li, PhD, Elizabeth Mullette, RN, MSN, and Jeannine M. Brant, PhD, APRN, AOCN®, FAAN


 
Section Seperator

TODAY'S NEWS

RSNA 2018: Mammography Screening Beyond ...

Women aged 75 years and older may benefit from con...

RSNA 2018: Breast Cancer Risk-Based Mamm...

A new, large-scale study of more than 5 million ma...

RSNA 2018: Preliminary Results of Primar...

Cryoablation has shown early indications of effect...

Eicosapentaenoic Acid and Aspirin in Pre...

In a trial reported in The Lancet by Hull et al, n...

Reducing Infections in Patients With AML...

In a report in the Journal of Oncology Practice, M...

More News From Today More News
Section Seperator

EDITORIALS & COMMENTARY

Trametinib in Metastatic Melanoma

Trametinib is a MEK inhibitor approved both as a single agent and in combination with dabrafenib...

Neratinib for HER2-Positive Breast Cancer

The treatment of breast cancer has been revolutionized by the development of HER2-targeted treatments...

Collaboration and Oral Chemotherapy Education

Providing comprehensive chemotherapy education to patients in a busy clinical practice setting can be challenging...

Painful Nodules and Recurrent Fever in ALL

Mr. S is a 39-year-old Hispanic male with a diagnosis of Philadelphia chromosome–negative ALL...

Thank You to Our Peer Reviewers!

We would like to acknowledge everyone who completed peer reviews for JADPRO in the past year...

More Editorials & Commentary More Tweets
 
Section Seperator

PREVIOUS HIGHLIGHTS

SELECT Trial: Adjuvant Erlotinib in Rese...

In a phase II trial reported in the Journal of Cli...

ASCO and Friends of Cancer Research Appl...

ASCO and Friends of Cancer Research applaud the Na...

FDA Pipeline: New Priority Reviews, Desi...

The ASCO Post summarizes recent drug designat...

Primary Resistance to Immune Checkpoint ...

In a study reported in JAMA Oncology, Cohen et al ...

POEMS/SWOG Intergroup S0230 Study on Pre...

In the long-term follow-up of the POEMS/SWOG Inter...

More Highlights More Highlights
Section Seperator

LATEST TWEETS







More Tweets More Tweets
 
Section Seperator
Section Seperator
 
 
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.